Cullen Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-263,870
| Closed | -$85.6M | – | 285 |
|
|
2022
Q2 | $85.6M | Sell |
263,870
-186,161
| -41% | -$55.9M | 0.86% | 42 |
|
|
2022
Q1 | $129M | Sell |
450,031
-4,732
| -1% | -$1.22M | 1.19% | 39 |
|
|
2021
Q4 | $126M | Sell |
454,763
-35,263
| -7% | -$8.94M | 1.18% | 40 |
|
|
2021
Q3 | $113M | Sell |
490,026
-9,483
| -2% | -$2.34M | 1.11% | 40 |
|
|
2021
Q2 | $115M | Buy |
499,509
+39,229
| +9% | +$7.88M | 1.11% | 40 |
|
|
2021
Q1 | $86M | Buy |
460,280
+325,310
| +241% | +$63.6M | 0.93% | 41 |
|
|
2020
Q4 | $22.8M | Hold |
134,970
| – | – | 1.27% | 37 |
|
|
2020
Q3 | $20M | Sell |
134,970
-39,685
| -23% | -$6.14M | 1.16% | 39 |
|
|
2020
Q2 | $28.7M | Sell |
174,655
-101,300
| -37% | -$15.5M | 1.61% | 30 |
|
|
2020
Q1 | $38.3M | Buy |
275,955
+2,285
| +0.8% | +$314K | 2.21% | 18 |
|
|
2019
Q4 | $36M | Sell |
273,670
-129,640
| -32% | -$15M | 1.41% | 36 |
|
|
2019
Q3 | $45.1M | Hold |
403,310
| – | – | 1.81% | 32 |
|
|
2019
Q2 | $44.7M | Buy |
403,310
+2,910
| +0.7% | +$343K | 1.74% | 27 |
|
|
2019
Q1 | $52M | Sell |
400,400
-129,205
| -24% | -$15.7M | 2.05% | 28 |
|
|
2018
Q4 | $61.3M | Hold |
529,605
| – | – | 2.64% | 12 |
|
|
2018
Q3 | $56.8M | Hold |
529,605
| – | – | 2.09% | 26 |
|
|
2018
Q2 | $45.2M | Sell |
529,605
-76,445
| -13% | -$6.28M | 1.71% | 33 |
|
|
2018
Q1 | $46.9M | Hold |
606,050
| – | – | 1.66% | 34 |
|
|
2017
Q4 | $51.2M | Hold |
606,050
| – | – | 1.76% | 34 |
|
|
2017
Q3 | $51.8M | Hold |
606,050
| – | – | 1.81% | 33 |
|
|
2017
Q2 | $49.9M | Hold |
606,050
| – | – | 1.75% | 33 |
|
|
2017
Q1 | $51M | Sell |
606,050
-93,070
| -13% | -$7.45M | 1.79% | 32 |
|
|
2016
Q4 | $51.4M | Sell |
699,120
-435
| -0.1% | -$32.4K | 1.77% | 30 |
|
|
2016
Q3 | $56.1M | Hold |
699,555
| – | – | 1.9% | 27 |
|
|
2016
Q2 | $55.1M | Hold |
699,555
| – | – | 1.94% | 25 |
|
|
2016
Q1 | $50.4M | Sell |
699,555
-19,615
| -3% | -$1.48M | 1.78% | 28 |
|
|
2015
Q4 | $60.6M | Hold |
719,170
| – | – | 2.05% | 24 |
|
|
2015
Q3 | $60.2M | Sell |
719,170
-365
| -0.1% | -$30.8K | 2.11% | 23 |
|
|
2015
Q2 | $60.1M | Sell |
719,535
-856,215
| -54% | -$65.2M | 1.92% | 26 |
|
|
2015
Q1 | $114M | Hold |
1,575,750
| – | – | 3.21% | 2 |
|
|
2014
Q4 | $109M | Hold |
1,575,750
| – | – | 2.95% | 11 |
|
|
2014
Q3 | $102M | Sell |
1,575,750
-509,300
| -24% | -$32.2M | 2.8% | 14 |
|
|
2014
Q2 | $130M | Hold |
2,085,050
| – | – | 3.37% | 3 |
|
|
2014
Q1 | $123M | Sell |
2,085,050
-700
| -0% | -$39.1K | 3.32% | 3 |
|
|
2013
Q4 | $106M | Hold |
2,085,750
| – | – | 2.8% | 11 |
|
|
2013
Q3 | $105M | Buy |
2,085,750
+36,250
| +2% | +$1.9M | 2.97% | 6 |
|
|
2013
Q2 | $101M | Buy |
+2,049,500
| New | +$112M | 3.06% | 7 |
|
Other funds holding LLY
Cullen Capital Management's LLY Position: Q3 2022 in Review
Cullen Capital Management sold out of Eli Lilly (LLY) in Q3 2022, closing a stake of 263,870 shares — an estimated $85.6M sold.
Cullen Capital Management first reported a position in LLY in Q2 2013 and held it in 37 quarters. The position peaked at $130M in Q2 2014. 2,485 funds tracked by Wall St. Rank hold LLY as of Q3 2022.
- Cullen Capital Management reported no remaining Eli Lilly position as of Q3 2022 after selling out during the quarter.
- Cullen Capital Management sold 263,870 Eli Lilly shares in Q3 2022, an estimated $85.6M.
- Cullen Capital Management first reported a position in Eli Lilly in Q2 2013 and held it in 37 quarters.
- Cullen Capital Management's Eli Lilly position peaked at $130M in Q2 2014.
- 2,485 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.
Based on Cullen Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.